Why is Nath Bio-Genes falling/rising?

As of 25-Aug, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 176.75, which reflects a decrease of Rs 1.25 or 0.7%. The stock has shown a performance today that is inline with its sector, but it touched an intraday low of Rs 173.25, marking a drop of 2.67%. The weighted average price indicates that more volume was traded closer to this low price. Additionally, the stock's performance over the past month shows a decline of 5.41%, and it has significantly underperformed the benchmark Sensex over the year, with a drop of 22.78% compared to the Sensex's increase of 0.68%. There is a notable decrease in investor participation, with delivery volume on August 22 falling by 94.85% against the 5-day average, which suggests a lack of interest among investors.
In the broader market context, the stock's short-term return of 1.70% over the past week is better than the Sensex's return of 0.45%, indicating some relative strength in the very short term. However, the longer-term performance is concerning, with a year-to-date decline of 6.11% compared to the Sensex's gain of 4.48%. This underperformance over longer periods, coupled with the falling investor participation and liquidity issues, suggests that the stock may be facing challenges that are impacting its price negatively. Overall, while there are no specific positive factors highlighted, the significant drop in trading volume and the stock's inability to maintain higher moving averages indicate a bearish sentiment among investors.